Rosacea Radiofrequency Microneedling
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Miami
About this trial
There are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic and or papulopustular rosacea, (2) to determine the potential for combination treatment of radiofrequency microneedling with the 532 nm KTP laser, and (3) identify potential novel therapeutic strategies for the treatment of rosacea.
Eligibility criteria
Qualifiers
Male or female adult (>18yo) subjects in general good health
Clinical and/or histologic diagnosis of erythematotelangiectatic or papulopustular rosacea.
Subject is able to understand and sign informed consent
Subject is able to complete the study and comply with study procedures
Disqualifiers
Patients currently utilizing oxymetazoline or brimonidine.
Presence of dermatoses that might interfere with diagnosis as determined by a study investigator
Presence of extreme light sensitivity, or conditions pre-disposing to light sensitivity such as but not limited to xeroderma pigmentosum
Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment
Trial design
Treatments tested in this trial
- KTP Laser Therapy
- Radiofrequency microneedling
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Miami
Lead sponsor
CynosureLutronic
Collaborator
Source ClinicalTrials.gov